Tag: Dr. Beatrice Langton-Webster

Cancer Targeted Technology gets NIH grant to support CTT1403 trial

pharmanewsdaily- August 7, 2020

Cancer Targeted Technology (CTT), a Seattle-based biotech company, has secured a grant of $1.44 million from the US National Institutes of Health (NIH) to support ... Read More